EUVIMEDEUVIMED entdecken
Crossref

Scoparone attenuates glioma progression and improves the toxicity of temozolomide by suppressing RhoA / ROCK1 signaling

Yuhao Zhou, Zhenying Han, Zilong Zhao, Jianning Zhang iD

Environmental Toxicology · 2024

DOI: 10.1002/tox.23882 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental Toxicology, 2024. Verfasst von Yuhao Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Glioma, Signal Transduction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glioma, a type of malignant brain tumor, has become a challenging health issue globally in recent years.

Methods

In this study, we investigated the potential therapeutic role of scoparone in glioma and the underlying mechanism. Initially, transcriptome sequencing was conducted to identify genes that exhibited differential expression in glioma cells treated with scoparone compared to untreated cells. Subsequently, the impact of scoparone on the proliferation, migration, and invasion of glioma cells was assessed in vitro using a range of assays including cell viability, colony formation, wound healing, and transwell assays. Moreover, the apoptotic effects of scoparone on glioma cells were evaluated through flow cytometry and western blot analysis. Furthermore, we established a glioma xenograft mouse model to assess the in vivo antitumor activity of scoparone. Lastly, by integrating transcriptome analysis, we endeavored to unravel the molecular mechanisms underlying the observed antitumor effects of scoparone by examining the expression levels of RhoA/ROCK1 signaling pathway components using western blot analysis and qRT‐PCR.

Results

Our transcriptome sequencing results revealed that scoparone significantly downregulated RhoA/ROCK1 signaling in glioma cells. Furthermore, scoparone treatment inhibited glioma cell proliferation, migration, and invasion, and promoted cell apoptosis in vitro. Moreover, scoparone reduced tumor growth and prolonged survival in a glioma xenograft mouse model, and improved the toxicity of temozolomide. Finally, our results showed that the antitumor effects of scoparone were mediated by the suppression of RhoA/ROCK1 signaling.

Conclusion

Scoparone could be a promising therapeutic agent for glioma by suppressing RhoA/ROCK1 signaling. These findings pave the way for future research endeavors aimed at the development and optimization of scoparone‐based therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaSignal TransductionAnimalsHumansMiceApoptosisCell Line, TumorCell MovementCell Proliferationrho-Associated KinasesTemozolomideCoumarins

Stichwörter der Autor:innen

ROCK1RhoAScoparonecell migrationglioma

Substanzen

rho-Associated KinasesROCK1 protein, humanscoparoneTemozolomideCoumarins

Autor:innen und Institutionen

  • Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China.

ORCID-Profile: Jianning Zhang

Zitieren

APA

Zhou, Y., Han, Z., Zhao, Z., & Zhang, J. (2024). Scoparone attenuates glioma progression and improves the toxicity of temozolomide by suppressing RhoA / ROCK1 signaling. Environmental Toxicology. https://doi.org/10.1002/tox.23882

Vancouver

Zhou Y, Han Z, Zhao Z, Zhang J. Scoparone attenuates glioma progression and improves the toxicity of temozolomide by suppressing RhoA / ROCK1 signaling. Environmental Toxicology. 2024. doi:10.1002/tox.23882

BibTeX
@article{Zhou2024,
  author = {Zhou, Yuhao and Han, Zhenying and Zhao, Zilong and Zhang, Jianning},
  title = {Scoparone attenuates glioma progression and improves the toxicity of temozolomide by suppressing RhoA / ROCK1 signaling},
  journal = {Environmental Toxicology},
  year = {2024},
  doi = {10.1002/tox.23882}
}
Kostenlos starten →